285 related articles for article (PubMed ID: 8815575)
21. The 1691 G-->A mutation in the factor V gene: relationship to activated protein C (APC) resistance and thrombosis in 65 patients.
Leroy-Matheron C; Levent M; Pignon JM; Mendonça C; Gouault-Heilmann M
Thromb Haemost; 1996 Jan; 75(1):4-10. PubMed ID: 8713771
[TBL] [Abstract][Full Text] [Related]
22. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
Dahlbäck B
Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
[TBL] [Abstract][Full Text] [Related]
23. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
[TBL] [Abstract][Full Text] [Related]
24. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
Dahlbäck B; Zöller B; Hillarp A
Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
Guasch JF; Lensen RP; Bertina RM
Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
[TBL] [Abstract][Full Text] [Related]
26. Female gender and resistance to activated protein C (FV:Q506) as potential risk factors for thrombosis after elective hip arthroplasty.
Svensson PJ; Benoni G; Fredin H; Björgell O; Nilsson P; Hedlund U; Nylander G; Bergqvist D; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):993-6. PubMed ID: 9308742
[TBL] [Abstract][Full Text] [Related]
27. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
Pereira J; Quiroga T; Goycoolea M; Muñoz B; Hidalgo P; Kaltwasser G; Mezzano D
Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
29. Activated protein C resistance assay performance: improvement by sample dilution with factor V-deficient plasma.
Strobl FJ; Hoffman S; Huber S; Williams EC; Voelkerding KV
Arch Pathol Lab Med; 1998 May; 122(5):430-3. PubMed ID: 9593344
[TBL] [Abstract][Full Text] [Related]
30. Laboratory assessment of hypercoagulable state. A study in a group of patients with venous thromboembolism born in Chioggia.
Gessoni G; Valverde S; Canistro R; Trabuio E; Antico F; Manoni F
Minerva Med; 2007 Apr; 98(2):89-93. PubMed ID: 17519850
[TBL] [Abstract][Full Text] [Related]
31. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
32. Thrombophilias and recurrent pregnancy loss.
Kutteh WH; Triplett DA
Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
[TBL] [Abstract][Full Text] [Related]
33. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of a new functional test for detection of activated protein C resistance (Pefakit APC-R Factor V Leiden) at two centers in Europe and the USA.
Schöni R; Quehenberger P; Wu JR; Wilmer M
Thromb Res; 2007; 119(1):17-26. PubMed ID: 16934314
[TBL] [Abstract][Full Text] [Related]
35. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
Tans G; Nicolaes GA; Rosing J
Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
[TBL] [Abstract][Full Text] [Related]
36. Prothrombin fragment F1+2 is not predictive for recurrent venous thromboembolism.
Kyrle PA; Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Melichart M; Traxler G; Weltermann A; Speiser W; Lechner K
Thromb Haemost; 1997 May; 77(5):829-33. PubMed ID: 9184387
[TBL] [Abstract][Full Text] [Related]
37. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
39. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
[TBL] [Abstract][Full Text] [Related]
40. Mutation in blood coagulation factor V associated with resistance to activated protein C.
Bertina RM; Koeleman BP; Koster T; Rosendaal FR; Dirven RJ; de Ronde H; van der Velden PA; Reitsma PH
Nature; 1994 May; 369(6475):64-7. PubMed ID: 8164741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
